Clinical Trial Update: HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCC [Phase 3]

View source ↗

Summary

Phase 3 trial comparing hepatic arterial infusion chemotherapy (HAIC) plus sorafenib versus transarterial chemoembolization (TACE) plus sorafenib in advanced he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED